| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +2% |
| 3Y CAGR | +7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +14% |
| 3Y CAGR | +10% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,416.10 +51.50 (2.18%) | 18,365.19 | 27.09 | 5.45 | ||
PfizerPFIZER | ₹3,834.70 +13.10 (0.34%) | 17,532.36 | 23.85 | 4.17 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,368.00 +23.00 (0.36%) | 15,912.75 | 93.81 | 18.23 | ||
Natco PharmaNATCOPHARM | ₹788.75 +7.15 (0.91%) | 15,489.42 | 13.53 | 1.48 |